These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29441120)

  • 1. Computational Insight into Protein Tyrosine Phosphatase 1B Inhibition: A Case Study of the Combined Ligand- and Structure-Based Approach.
    Zhang X; Jiang H; Li W; Wang J; Cheng M
    Comput Math Methods Med; 2017; 2017():4245613. PubMed ID: 29441120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of enzyme inhibition and mode of inhibitory action based on calculation of distances between hydrogen bond donor/acceptor groups of the molecule and docking analysis: An application on the discovery of novel effective PTP1B inhibitors.
    Eleftheriou P; Petrou A; Geronikaki A; Liaras K; Dirnali S; Anna M
    SAR QSAR Environ Res; 2015; 26(7-9):557-76. PubMed ID: 26294069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coumarins from Angelica decursiva inhibit α-glucosidase activity and protein tyrosine phosphatase 1B.
    Ali MY; Jannat S; Jung HA; Jeong HO; Chung HY; Choi JS
    Chem Biol Interact; 2016 May; 252():93-101. PubMed ID: 27085377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
    Eleftheriou P; Geronikaki A; Petrou A
    Curr Top Med Chem; 2019; 19(4):246-263. PubMed ID: 30714526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the inhibitory activity of natural tanshinones from Salvia miltiorrhiza roots on protein tyrosine phosphatase 1B.
    Kim DH; Paudel P; Yu T; Ngo TM; Kim JA; Jung HA; Yokozawa T; Choi JS
    Chem Biol Interact; 2017 Dec; 278():65-73. PubMed ID: 29031618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of 4,4-dimethyl lithocholic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.
    He HB; Gao LX; Deng QF; Ma WP; Tang CL; Qiu WW; Tang J; Li JY; Li J; Yang F
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7237-42. PubMed ID: 23067554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of formylchromane derivatives as protein tyrosine phosphatase 1B inhibitors by pharmacophore modeling, atom-based 3D-QSAR and docking studies.
    Malla P; Kumar R; Kumar M
    Chem Biol Drug Des; 2013 Jul; 82(1):71-80. PubMed ID: 23506477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational revelation of binding mechanisms of inhibitors to endocellular protein tyrosine phosphatase 1B using molecular dynamics simulations.
    Yan F; Liu X; Zhang S; Su J; Zhang Q; Chen J
    J Biomol Struct Dyn; 2018 Nov; 36(14):3636-3650. PubMed ID: 29048995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico modelling and molecular dynamics simulation studies of thiazolidine based PTP1B inhibitors.
    Mahapatra MK; Bera K; Singh DV; Kumar R; Kumar M
    J Biomol Struct Dyn; 2018 Apr; 36(5):1195-1211. PubMed ID: 28393626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The design strategy of selective PTP1B inhibitors over TCPTP.
    Li X; Wang L; Shi D
    Bioorg Med Chem; 2016 Aug; 24(16):3343-52. PubMed ID: 27353889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated use of ligand and structure-based virtual screening, molecular dynamics, free energy calculation and ADME prediction for the identification of potential PTP1B inhibitors.
    Devi B; Vasishta SS; Das B; Baidya ATK; Rampa RS; Mahapatra MK; Kumar R
    Mol Divers; 2024 Apr; 28(2):649-669. PubMed ID: 36745307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico investigations on the binding efficacy and allosteric mechanism of six different natural product compounds towards PTP1B inhibition through docking and molecular dynamics simulations.
    SarathKumar B; Lakshmi BS
    J Mol Model; 2019 Aug; 25(9):272. PubMed ID: 31451955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Docking, In-Silico ADMET Study and Development of 1,6- Dihydropyrimidine Derivative as Protein Tyrosine Phosphatase Inhibitor: An Approach to Design and Develop Antidiabetic Agents.
    Patel AD; Barot R; Parmar I; Panchal I; Shah U; Patel M; Mishtry B
    Curr Comput Aided Drug Des; 2018; 14(4):349-362. PubMed ID: 29701158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Basis of Fullerene Derivatives as Novel Potent Inhibitors of Protein Tyrosine Phosphatase 1B: Insight into the Inhibitory Mechanism through Molecular Modeling Studies.
    Qian M; Shan Y; Guan S; Zhang H; Wang S; Han W
    J Chem Inf Model; 2016 Oct; 56(10):2024-2034. PubMed ID: 27649447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Dynamics Simulations of A27S and K120A Mutated PTP1B Reveals Selective Binding of the Bidentate Inhibitor.
    Chen X; Liu X; Gan Q; Feng C; Zhang Q
    Biomed Res Int; 2019; 2019():9852897. PubMed ID: 30729132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diphenylether derivative as selective inhibitor of protein tyrosine phosphatase 1B (PTP1B) over t-cell protein tyrosine phosphatase (TCPTP) identified through virtual screening.
    Reddy MV; Ghadiyaram C; Panigrahi SK; Hosahalli S; Mangamoori LN
    Mini Rev Med Chem; 2013 Oct; 13(11):1602-6. PubMed ID: 24000798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel, potent, selective and cellular active ADC type PTP1B inhibitors via fragment-docking-oriented de novel design.
    Du Y; Ling H; Zhang M; Shen J; Li Q
    Bioorg Med Chem; 2015 Aug; 23(15):4891-4898. PubMed ID: 26100442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual Screening of Novel and Selective Inhibitors of Protein Tyrosine Phosphatase 1B over T-Cell Protein Tyrosine Phosphatase Using a Bidentate Inhibition Strategy.
    Chen X; Gan Q; Feng C; Liu X; Zhang Q
    J Chem Inf Model; 2018 Apr; 58(4):837-847. PubMed ID: 29608303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-induced conformational changes: improved predictions of ligand binding conformations and affinities.
    Frimurer TM; Peters GH; Iversen LF; Andersen HS; Møller NP; Olsen OH
    Biophys J; 2003 Apr; 84(4):2273-81. PubMed ID: 12668436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent protein tyrosine phosphatase 1B (PTP1B) inhibiting constituents from Anoectochilus chapaensis and molecular docking studies.
    Cai J; Zhao L; Tao W
    Pharm Biol; 2015 Jul; 53(7):1030-4. PubMed ID: 25609152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.